<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A sensitive F-cell assay has been used to examine the production of fetal <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> (Hb F) in a group of 77 adult patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and a control group composed of 100 <z:mpath ids='MPATH_458'>normal</z:mpath> blood donors </plain></SENT>
<SENT sid="1" pm="."><plain>Although the mean F-cell percentage in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> group (6.0%) is not statistically different from that in the <z:mpath ids='MPATH_458'>normal</z:mpath> blood donors (3.1%), a higher proportion of myelodysplastic patients have elevated F-cell values and the magnitude of the increases is greater than that observed in blood donors </plain></SENT>
<SENT sid="2" pm="."><plain>In order to investigate the association further, the karyotypes of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients have been examined </plain></SENT>
<SENT sid="3" pm="."><plain>13/21 (61.9%) of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with karyotypic abnormalities have F-cell values &gt; 5%, compared to only 6/56 (10.9%) of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype and 11/100 (11%) of the blood donors </plain></SENT>
<SENT sid="4" pm="."><plain>The observed difference in the distributions of F cells between the two subgroups of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is highly significant (P &lt; 0.0001) </plain></SENT>
</text></document>